The combination of accelerating revenue growth, first full-year profitability, strong cash flow, and a significant buyback suggests improving fundamentals and confidence in future growth. The 2026 guidance for continued margin expansion is particularly positive. Traders should monitor execution on AI and innovation initiatives mentioned by management.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Feb 26 $25.65entry
- T+1 · 9mo ago −2.50%α −2.04% · $25.01
- T+5 · 9mo ago +4.76%α +5.88% · $26.87
- T+20 · 8mo ago −14.27%α −7.87% · $21.99
- T+60 · 6mo ago −4.48%α −12.23% · $24.50
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Warby Parker reported strong full-year 2025 results with 13.0% revenue growth and achieved its first full year of positive net income ($1.6M). Adjusted EBITDA expanded 30.2% to $95.2M, and the company generated $43.7M in free cash flow. It also announced a $100M share repurchase program and provided 2026 guidance for 10-12% revenue growth and 130bps EBITDA margin expansion.
Key Financial Metrics
Key Facts
- Full-year 2025 revenue of $871.9M, up 13.0% YoY
- First full year of positive net income: $1.6M
- Adjusted EBITDA of $95.2M, up 30.2% YoY, with margin expansion of 140bps to 10.9%
- Generated $43.7M in free cash flow, third consecutive year of positive FCF
- Authorized $100M share repurchase program
- 2026 guidance: $959M-$976M revenue (10-12% growth) and $117M-$119M Adjusted EBITDA (12.2% margin)
Financial Impact
Revenue up $100.6M YoY, net income improved $22.0M, Adjusted EBITDA up $22.1M YoY. $100M share repurchase authorized. 2026 revenue guidance implies $87.1M-$104.1M growth.
Risk Factors
- Gross margin declined 130bps YoY due to tariffs, doctor headcount, and shipping costs
- Guidance and financials are non-GAAP and exclude significant items like stock-based compensation
- Forward-looking statements are subject to risks including economic conditions, supply chain, and competition
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001504776-26-000003 |
| Document: wrby-20260226.htm | 0001504776-26-000003 |
| Document: 0001504776-26-000003-index-headers.html | 0001504776-26-000003 |
| Document: 0001504776-26-000003-index.html | 0001504776-26-000003 |
| Document: 0001504776-26-000003.txt | 0001504776-26-000003 |
Track record
17 reports on WRBY
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +19.75% at T+5 after the Sep 22, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $27.42 Now $26.23 +4.34% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $27.44 Now $26.23 −4.41% settles Nov 20
- Nov 9, 20267d ago 144 Neutral 3/10 Entry $29.90 Now $26.23 −12.27% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $29.90 Now $26.23 −12.27% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $29.90 Now $26.23 −12.27% settles Nov 17
- Nov 5, 202611d ago 8-K Bearish 5/10 Entry $26.08 to $26.73 Now $26.23 −0.58% ▼ −2.49% +0.80% vs SPY
- Oct 2, 20266w ago Insider Cluster Bearish 5/10 Entry $26.65 to $25.99 Now $26.23 +1.58% ▲ +2.48% +2.90% vs SPY
- Sep 22, 20267w ago Institutional Cluster Bullish 4/10 Entry $22.94 to $27.47 Now $26.23 +14.34% ▲ +19.75% +20.93% vs SPY
- Jul 8, 202618w ago Insider Cluster Neutral 4/10 Entry $29.32 to $27.59 Now $26.23 −10.54% ▼ −5.90% −5.77% vs SPY
- Jul 2, 202619w ago Insider Cluster Neutral 2/10 Entry $29.26 to $29.32 Now $26.23 −10.36% ▲ +0.21% −0.73% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers